Stock Scorecard



Stock Summary for Humacyte Inc (HUMA) - $1.58 as of 8/22/2025 8:12:18 PM EST

Total Score

6 out of 30

Safety Score

25 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for HUMA

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for HUMA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for HUMA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for HUMA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for HUMA (25 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for HUMA

Is It Worth Investing in Humacyte, Inc. ( HUMA ) Based on Wall Street's Bullish Views? 8/20/2025 1:30:00 PM
Humacyte, Inc. ( HUMA ) Reports Q2 Loss, Misses Revenue Estimates 8/11/2025 12:15:00 PM
Humacyte Posts Q2 Revenue Miss 8/11/2025 11:20:00 AM
Humacyte, Inc. ( HUMA ) Stock Dips While Market Gains: Key Facts 8/6/2025 10:00:00 PM
Humacyte, Inc. ( HUMA ) Suffers a Larger Drop Than the General Market: Key Insights 7/31/2025 10:00:00 PM
Humacyte, Inc. ( HUMA ) Stock Dips While Market Gains: Key Facts 7/25/2025 10:00:00 PM
Humacyte, Inc. ( HUMA ) Stock Falls Amid Market Uptick: What Investors Need to Know 7/24/2025 10:15:00 PM
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma ( NASDAQ:ARWR ) , Abivax ( NASDAQ:ABVX ) 7/23/2025 3:00:00 PM
Humacyte Announces First Symvess™ Sale to Military Treatment Facility - Humacyte ( NASDAQ:HUMA ) 7/23/2025 12:00:00 PM
Humacyte, Inc. ( HUMA ) Dips More Than Broader Market: What You Should Know 7/18/2025 10:00:00 PM

Financial Details for HUMA

Company Overview

Ticker HUMA
Company Name Humacyte Inc
Country USA
Description N/A
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name BLANK CHECKS
Most Recent Quarter 6/30/2025
Next Earnings Date 11/7/2025

Stock Price History

Last Day Price 1.58
Price 4 Years Ago 7.25
Last Day Price Updated 8/22/2025 8:12:18 PM EST
Last Day Volume 3,555,059
Average Daily Volume 5,410,434
52-Week High 7.48
52-Week Low 1.15
Last Price to 52 Week Low 37.39%

Valuation Measures

Trailing PE N/A
Industry PE 83.32
Sector PE 67.51
5-Year Average PE -6.99
Free Cash Flow Ratio 6.58
Industry Free Cash Flow Ratio 90.39
Sector Free Cash Flow Ratio 82.17
Current Ratio Most Recent Quarter 2.45
Total Cash Per Share 0.24
Book Value Per Share Most Recent Quarter 0.03
Price to Book Ratio 62.34
Industry Price to Book Ratio 5.05
Sector Price to Book Ratio 13.27
Price to Sales Ratio Twelve Trailing Months 308.81
Industry Price to Sales Ratio Twelve Trailing Months 1.64
Sector Price to Sales Ratio Twelve Trailing Months 4.91
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 158,372,000
Market Capitalization 250,227,760
Institutional Ownership 36.53%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -34.24%
Reported EPS 12 Trailing Months -0.47
Reported EPS Past Year -0.32
Reported EPS Prior Year -1.31
Net Income Twelve Trailing Months -58,661,000
Net Income Past Year -148,701,000
Net Income Prior Year -110,776,000
Quarterly Revenue Growth YOY -100.00%
5-Year Revenue Growth -100.00%
Operating Margin Twelve Trailing Months -9,876.00%

Balance Sheet

Total Cash Most Recent Quarter 38,032,000
Total Cash Past Year 44,937,000
Total Cash Prior Year 80,448,000
Net Cash Position Most Recent Quarter -24,085,000
Net Cash Position Past Year 6,337,000
Long Term Debt Past Year 38,600,000
Long Term Debt Prior Year 38,600,000
Total Debt Most Recent Quarter 62,117,000
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter 0.06
Total Stockholder Equity Past Year -52,669,000
Total Stockholder Equity Prior Year 13,546,000
Total Stockholder Equity Most Recent Quarter 4,052,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -106,291,000
Free Cash Flow Per Share Twelve Trailing Months -0.67
Free Cash Flow Past Year -99,694,000
Free Cash Flow Prior Year -75,585,000

Options

Put/Call Ratio 7.05
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.19
MACD Signal -0.13
20-Day Bollinger Lower Band 1.17
20-Day Bollinger Middle Band 2.08
20-Day Bollinger Upper Band 2.99
Beta 1.90
RSI 31.99
50-Day SMA 3.57
150-Day SMA 3.69
200-Day SMA 4.27

System

Modified 8/21/2025 2:25:50 AM EST